Symbols

DMAA

Drugs Made In·NASDAQ

--(--)

7.43 / 10

Outperform

Fund flow analysis scores 7.43/10, indicating robust fund flow characteristics. Bullish trends in overall, block, Medium, Large, and Extra-large contrast with bearish signals in Small, suggesting positive liquidity momentum.

Fund Flow Rating

What is the market sentiment for DMAA?

DMAA holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.43/10 (Outperform).